New Articles -- EvidenceUpdates: Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Saturday, October 15, 2016

New Articles -- EvidenceUpdates: Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis



  1. abstract + comment
   Trials of longer duration are needed to assess the long-term effectiveness and safety of dupilumab.

 2. NEJM - abstract
(Funded by Sanofi and Regeneron Pharmaceuticals; SOLO 1 ClinicalTrials.gov number, NCT02277743; SOLO 2 ClinicalTrials.gov number, NCT02277769.)

0 comments :

Post a Comment

Your comments?